Rational Use of Bethanechol in Dogs and Cats with Bladder Dysfunction

Area of Science:

• Veterinary Pharmacology
• Urology
• Neurology

Background:

• Bethanechol chloride is a common drug used in veterinary medicine to treat bladder emptying issues in dogs and cats.
• It acts as a muscarinic agonist, promoting detrusor smooth muscle contraction.
• Potential side effects include urethral smooth muscle contraction due to nicotinic receptor stimulation at higher doses.

Purpose of the Study:

• To evaluate the efficacy and contraindications of bethanechol chloride in various bladder dysfunction scenarios in animals.
• To understand the drug's mechanism in relation to neurological lesions affecting urination.

Main Methods:

• Review of bethanechol chloride's pharmacological action.
• Analysis of its use in conditions with suprasacral lesions, sacral segment injuries, cauda equina or pelvic nerve damage.
• Consideration of its application in myopathic decompensated bladders.

Main Results:

• Bethanechol is contraindicated in total or partial suprasacral lesions due to expected urethral hypertonicity.
• It is ineffective in complete sacral segment, cauda equina, or pelvic nerve injuries.
• Bethanechol is likely effective in partial nerve injuries and may benefit myopathic decompensated bladders, depending on detrusor damage severity.

Conclusions:

• Bethanechol chloride's effectiveness is highly dependent on the type and extent of neurological or muscular damage affecting bladder function.
• Careful patient selection is crucial to avoid contraindications and ensure therapeutic benefit in veterinary urology.